CClinicalTrials.gg
RecruitingNCT04498598Updated May 7, 2026

Structural Modification In Supraglottic Airway Device

An interventional study of A/Z Supraglottic airway in Airway Complication of Anesthesia, Ventilation Therapy; Complications and Hypoxia, sponsored by The Cleveland Clinic. Recruiting at 1 site in United States. Open to participants aged 18 Years to 100 Years. Per ClinicalTrials.gov, last updated 2026-05-07.

Sponsored by The Cleveland Clinic · Not applicable, Interventional, and Device feasibility

Phase
Not applicable
Study type
Interventional
Enrollment
100
Allocation
Not applicable
Ages
18 Years to 100 Years
Sex
All
01

Study summary

The proposed A/Z modification of a supraglottic airway (SGA) incorporates an opening in the SGA body that enables access to the endotracheal tube (ETT) through the body of the SGA without the need of using an exchange catheter, thus enabling an ETT to move in the body of the SGA and convert a supraglottic to endotracheal ventilation. In its original form an adaptor made from same material currently used in the endotracheal tubes can make ventilation through the proposed airway device possible in exactly the same manner of a conventional SGA currently used. This adapter also known as the R-piece can be replaced with an ETT. The modification also allows placement of SGA over an existing ETT to convert and endotracheal (ET) to supraglottic (SG) mode of ventilation without the need to use an exchange catheter.

Read the detailed description

The special design allows conversion of a telescopic coaxial portion (R piece), replacing with an ETT which can act coaxially to provide both supraglottic (up position) and endotracheal (down position) of ETT. See this modification in https://www.youtube.com/watch?v=iy84lALU1aI

Currently the proposed change to the conventional SGA has been made and feasibility tested on Manikins. The A/Z airway modification is also demonstrated in the attached link video https://www.youtube.com/watch?v=ukLOAC55iG8

In this study, we are trialing the A/Z concept on an original A/Z modification by a manufacturer on their currently used SGA. Thus instead of investigators making the changes by cutting a channel in a conventional SGA immediately before use in the Operating Room, they have asked a manufacturer to do so professionally.

02

Conditions studied

  • Airway Complication of Anesthesia
  • Ventilation Therapy; Complications
  • Hypoxia
  • Hypoventilation

Keywords

  • Airway Management
  • Oxygenation and Ventilation
  • Airway Devices
  • Supraglottic Airway
03

Who can participate

Ages eligible
18 Years to 100 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  1. Adult patients
  2. scheduled for a general anesthesia procedure with ETT \& muscle relaxation

Exclusion criteria

Exclusion Criteria:

  1. Patients who are not able to consent
  2. Non English Speaking
  3. History of difficult airway
  4. Physical exam of airway which suggests difficulty in airway management or need to use special equipment
  5. BMI >35
  6. Gastroesophageal reflux disease
  7. Anesthetic plan other than general anesthesia
  8. Emergency procedures
04

Study design

Phase
Not applicable
Primary purpose
Device feasibility
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
100 participants (estimated)

Study arms

  • Experimental
    A/Z Airway

    Patients under general anesthesia for surgical procedures who need airway management for ventilation.

    Device: A/Z Supraglottic airway

Interventions

  • DeviceA/Z Supraglottic airway

    Patient receive supraglottic airway for general anesthesia which can be converted to endotracheal ventilation reversibly

05

What researchers measure

Primary outcomes

  1. Test effect of A/Z modification of supraglottic airway device on rate of successful oxygenation and ventilation before beginning a full clinical trial

    An alteration and structural modification in the supraglottic airway device can improve safety of airway exchange in patient needing general anesthesia, this proof of concept should show if the modification has any affect on oxygenation and ventilation.

    Time frame: During and immediately after the intervention

Secondary outcomes

  1. Rate of successful exchange from supraglottic to endotracheal ventilation using A/Z modified SGA

    Evaluate if a modification of configuration on "Laryngeal Mask Airway" improves safety during Supraglottic to Endotracheal conversion without using an exchange catheter

    Time frame: During and immediately after intervention

  2. Rate of successful exchange from endotracheal to supraglottic ventilation using A/Z modified SGA

    Evaluate if this modification can enhance smooth extubation after endotracheal intubation by converting an endotracheal tube to a supraglottic airway

    Time frame: During and immediately after intervention

06

Study locations

1 of 1 sites recruiting
  • Cleveland Clinic Foundation
    Cleveland, Ohio 44195, United States
    Recruiting
07

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

08

Registry details

Key details

Study ID
NCT04498598
Lead sponsor
The Cleveland Clinic
Responsible party
Sponsor
First posted
Aug 4, 2020
Start date
Sep 30, 2020
Primary completion
Aug 24, 2026 (estimated)
Completion
Aug 24, 2026 (estimated)
Last update
May 7, 2026

Study contacts

Rafi Avitsian, MD
Contact
avitsir@ccf.org
216-444-9735
Mark Mettler
Contact
mettlem@ccf.org
216-445-8281

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
Yes
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion